| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.0092 | 0.9 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |